Popovits Kimberly J Insider Trades

Insider Trading History

Track insider trading activity for Popovits Kimberly J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
10x Genomics
10x Genomics TXG
Director
Holding Value $1.71M 37,445 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 8,829 shares
$33.50
$45.79
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$135k 2,799 shares
$48.38
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $754k 12,158 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$686k 14,184 shares
$48.38
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $951k 15,345 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$135k 2,799 shares
$48.38
$61.98
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.13M 10,257 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 17,065 shares
$88.12
$109.96
Exact Sciences
Exact Sciences EXAS
Director
Holding Value $1.01M 9,656 shares
Last Trade
Mar 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.72M 16,381 shares
$104.91
$104.91
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $778k 12,546 shares
Last Trade
Jul 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.88M 129,016 shares
$30.06
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $4.78M 77,054 shares
Last Trade
Jul 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.94M 64,508 shares
$30.06
$61.98
Exact Sciences
Exact Sciences EXAS
Director
Holding Value $1.72M 16,381 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$540k 9,994 shares
$54.01
$104.91
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $0 0 shares
Last Trade
Jun 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.7k 3,173 shares
$29.52
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $778k 12,546 shares
Last Trade
Jun 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.7k 3,173 shares
$29.52
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $1.04M 16,798 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$570k 19,597 shares
$29.11
$61.98
10x Genomics
10x Genomics TXG
Director
Holding Value $1.31M 28,616 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 15,357 shares
$9.11
$45.79
Exact Sciences
Exact Sciences EXAS
Director
Holding Value $670k 6,387 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 6,387 shares
$56.92
$104.91
10x Genomics
10x Genomics TXG
Director
Holding Value $607k 13,259 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187k 8,649 shares
$21.58
$45.79
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $581k 9,373 shares
Last Trade
Jun 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.4k 4,373 shares
$19.52
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $0 0 shares
Last Trade
Jun 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.4k 4,373 shares
$19.52
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $1.18M 19,040 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 19,040 shares
$19.71
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $310k 5,000 shares
Last Trade
Jun 29, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.8k 5,000 shares
$14.35
$61.98
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $0 0 shares
Last Trade
Jun 29, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.8k 5,000 shares
$14.35
$61.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up